Molla A, Yamamoto T, Akaike T, Miyoshi S, Maeda H
Department of Microbiology, Kumamoto University Medical School, Japan.
J Biol Chem. 1989 Jun 25;264(18):10589-94.
Activation of the Hageman factor-kallikrein-kinin system by serratial 56-kDa proteinase was previously demonstrated (Matsumoto, K., Yamamoto, T., Kamata, T., and Maeda, H. (1984) J. Biochem. (Tokyo) 96, 739-749; Kamata, R., Yamamoto, T., Matsumoto, K., and Maeda, H. (1985) Infect. Immun. 48, 747-753). To investigate whether the activation of the system is specific for 56-kDa proteinase or is found similarly with other microbial proteinases, 11 proteinases of microbial origins were studied; the 56-kDa proteinase was the control. For in vitro studies, activation of guinea pig Hageman factor and prekallikrein was examined in purified systems as well as in plasma as a zymogen source. Specific antibodies and inhibitors confirmed the activation steps of the cascade. In the in vivo study the enhancement of vascular permeability in guinea pig skin and its sensitivity to inhibitors of activated Hageman factor, plasma kallikrein, or a kininase were examined. The results from the in vivo experiments were consistent with those in vitro. Taking all the data together, we classified the 11 microbial proteinases into three groups as follows: 1) Serratia marcescens 56-, 60-, and 73-kDa proteinases, Pseudomonas aeruginosa alkaline proteinase and elastase, and Aspergillus melleus proteinase (this group activated Hageman factor but not prekallikrein); 2) Vibrio vulnificus proteinase, subtilisin from Bacillus subtilis, and thermolysin from Bacillus stearothermophilus (this group activated both Hageman factor and prekallikrein); 3) Streptomyces caespitosus proteinase and V8 proteinase from Staphylococcus aureus (this group activated neither Hageman factor nor prekallikrein, but generated kinin from high molecular weight kininogen directly).
先前已证实,沙雷氏菌56 kDa蛋白酶可激活Hageman因子-激肽释放酶-激肽系统(松本健、山本彻、蒲田隆、前田博,(1984年)《生物化学杂志》(东京)96卷,739 - 749页;蒲田隆、山本彻、松本健、前田博,(1985年)《感染与免疫》48卷,747 - 753页)。为了研究该系统的激活是56 kDa蛋白酶特有的,还是其他微生物蛋白酶也有类似情况,我们研究了11种微生物来源的蛋白酶;以56 kDa蛋白酶作为对照。对于体外研究,在纯化系统以及以血浆作为酶原来源的情况下,检测豚鼠Hageman因子和前激肽释放酶的激活情况。特异性抗体和抑制剂证实了级联反应的激活步骤。在体内研究中,检测了豚鼠皮肤血管通透性的增强及其对激活的Hageman因子、血浆激肽释放酶或激肽酶抑制剂的敏感性。体内实验结果与体外实验结果一致。综合所有数据,我们将这11种微生物蛋白酶分为以下三组:1)粘质沙雷氏菌56 kDa、60 kDa和73 kDa蛋白酶、铜绿假单胞菌碱性蛋白酶和弹性蛋白酶以及黄曲霉蛋白酶(该组激活Hageman因子,但不激活前激肽释放酶);2)创伤弧菌蛋白酶、枯草芽孢杆菌枯草杆菌蛋白酶和嗜热脂肪芽孢杆菌嗜热菌蛋白酶(该组激活Hageman因子和前激肽释放酶);3)头状链霉菌蛋白酶和金黄色葡萄球菌V8蛋白酶(该组既不激活Hageman因子也不激活前激肽释放酶,但可直接从高分子量激肽原生成激肽)。